Defining the role of SGAs in the long-term treatment of bipolar disorder

Bipolar Disord. 2017 Feb;19(1):65-67. doi: 10.1111/bdi.12472.

Authors

Gin S Malhi^{1

2

3}, Grace Morris^{1

2

3}, Amber Hamilton^{1

2

3}, Tim Outhred^{1

2

3}, Pritha Das^{1

2

3}

Affiliations

¹ Academic Department of Psychiatry, Northern Sydney Local Health District, St Leonards, NSW, Australia.
² Sydney Medical School Northern, University of Sydney, Sydney, NSW, Australia.
³ CADE Clinic, Royal North Shore Hospital, Northern Sydney Local Health District, St Leonards, NSW, Australia.

PMID: 28346768
DOI: 10.1111/bdi.12472

No abstract available

Keywords: bipolar disorder; maintenance treatment; second-generation antipsychotics.

Publication types

Comment

MeSH terms

Antipsychotic Agents*
Bipolar Disorder*
Humans
Long-Term Care

Substances

Antipsychotic Agents